Zevra Therapeutics, Inc. (ZVRA)
11.13
+0.13
(+1.18%)
USD |
NASDAQ |
May 08, 16:00
11.36
+0.23
(+2.07%)
After-Hours: 04:18
Zevra Therapeutics EPS Diluted (Quarterly) : 0.603 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -0.3954 |
| Journey Medical Corp. | -0.0459 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Johnson & Johnson | 2.141 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 36.32M |
| Revenue (Quarterly) | 36.22M |
| Total Expenses (Quarterly) | -0.097M |
| Enterprise Value | 458.48M |
| Gross Profit Margin (Quarterly) | 93.75% |
| Earnings Yield | 19.35% |
| Operating Earnings Yield | 1.55% |
| Normalized Earnings Yield | 27.37 |